oxyquinoline sulfate

Small moleculeexperimental

In cosmetics and personal care products, Benzoxiquine has been reported to be used in the formulation of hair tonics, dressings, and other hair grooming aids. Benzoxiquine is described as a biocide for use in cosmetic products. It is currently reported to be used in only one product. In a separate finding, the Food and Drug Administration determined that Benzoxiquine is not generally recognized as safe and effective in over-the-counter topical antifungal drug products. The only data available on the toxicity of Benzoxiquine indicates that it is mutagenic in the Ames test without metabolic activation. Because of the lack of data, the safety of Benzoxiquine could not be substantiated. The data needed to make a safety assessment include purity/impurities, ultraviolet absorption (if there is absorption, then photosensitization data will be needed), 28-day dermal toxicity, dermal teratogenicity, ocular irritation (if already available only), dermal irritation and sensitization, and two different genotoxicity studies (one using a mammalian system). If the latter data are positive, dermal carcinogenesis data using the methods of the National Toxicology Program will be needed. It cannot be concluded that Benzoxiquine is safe for use in cosmetic products until these safety data have been obtained and evaluated. — NCATS

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0

Earliest trial started Sep 1, 2009 (NCT01471457)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Loading structure…

SMILES

OC1=C2N=CC=CC2=CC=C1
Mol. weight
145.158 g/mol

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 8-hydroxyquinoline
  • 8-hydroxyquinoline
  • 8-hydroxyquinoline
  • 8-quinolinol
  • hydroxybenzopyridine
  • hydroxybenzopyridine
  • hydroxyquinoline
  • hydroxyquinoline
  • hydroxyquinoline
  • oxine
  • oxine
  • oxyquinoline
  • oxyquinoline
  • oxyquinoline
  • oxyquinoline
  • oxyquinoline sulfate
  • phenopyridine
  • phenopyridine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01471457Phase 2/Phase 3 (Phase 3)Sep 1, 2009University of New Mexico
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of New MexicoAcademic/Hospital1112009
1 organizations
Page 1 / 1